Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flow

v3.7.0.1
Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash provided by (used in) Operating activities    
Net income (loss) for the period $ 5,189 $ (2,989)
Items not affecting cash:    
Stock based expense 287 209
Depreciation and amortization 1,287 1,257
Accretion of asset retirement obligation 132 132
Amortization of deferred loan costs 29 38
Write off of equity investments   189
Warrants mark to market gain   (31)
Gain on disposition of assets   (37)
Loss (gain) on foreign exchange (8) 200
RSUs redeemed to pay withholding or paid in cash (52) (9)
Proceeds from assignment of sales contract   5,085
Change in non-cash working capital items:    
Accounts receivable (2) (4)
Inventory (1,652) (2,590)
Prepaid expenses 87 (72)
Accounts payable and accrued liabilities 1,217 727
Net Cash Provided by (Used in) Operating Activities, Total 6,514 2,105
Investing activities    
Proceeds from sale of property and equipment   59
Purchase of capital assets (10) (70)
Net Cash Provided by (Used in) Investing Activities, Total (10) (11)
Financing activities    
Issuance of common shares and warrants for cash 1,169 6,461
Share issue costs (43) (608)
Proceeds from exercise of stock options 348 9
Repayment of debt (1,131) (2,147)
Net Cash Provided by (Used in) Financing Activities, Total 343 3,715
Effects of foreign exchange rate changes on cash (6) 66
Net change in cash and cash equivalents 6,841 5,875
Beginning cash and cash equivalents 9,109  
Ending cash and cash equivalents (note 13) $ 15,950 $ 14,875